Wellington Management Group LLP Takes $111,000 Position in Cibus, Inc. (NASDAQ:CBUS)

Wellington Management Group LLP bought a new position in shares of Cibus, Inc. (NASDAQ:CBUS) in the third quarter, according to the company in its most recent filing with the SEC. The firm bought 33,962 shares of the company’s stock, valued at approximately $111,000.

Other hedge funds have also made changes to their positions in the company. FMR LLC raised its position in Cibus by 16.9% in the 3rd quarter. FMR LLC now owns 3,913,279 shares of the company’s stock valued at $12,757,000 after purchasing an additional 566,328 shares during the last quarter. Armistice Capital LLC acquired a new stake in Cibus in the 2nd quarter valued at about $5,083,000. State Street Corp raised its stake in shares of Cibus by 43.6% in the third quarter. State Street Corp now owns 307,262 shares of the company’s stock worth $1,002,000 after acquiring an additional 93,236 shares during the last quarter. Bank of New York Mellon Corp bought a new position in shares of Cibus in the second quarter worth about $529,000. Finally, Swan Global Investments LLC acquired a new position in shares of Cibus during the third quarter worth approximately $115,000. Institutional investors and hedge funds own 33.81% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on the stock. HC Wainwright reissued a “buy” rating and issued a $25.00 price target on shares of Cibus in a report on Monday, November 11th. Canaccord Genuity Group reissued a “buy” rating and issued a $20.00 target price on shares of Cibus in a research note on Tuesday, October 22nd. Finally, Alliance Global Partners cut their price target on Cibus from $25.00 to $23.50 and set a “buy” rating on the stock in a research note on Tuesday, September 24th.

Cibus Price Performance

Shares of NASDAQ:CBUS opened at $2.64 on Friday. The company has a 50 day moving average of $4.16 and a 200-day moving average of $6.24. Cibus, Inc. has a one year low of $2.37 and a one year high of $23.18. The stock has a market cap of $69.84 million, a price-to-earnings ratio of -0.12 and a beta of 1.86.

About Cibus

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.